| Market revenue in 2025 | USD 16.5 million |
| Market revenue in 2033 | USD 62.2 million |
| Growth rate | 18.1% (CAGR from 2026 to 2033) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Services |
| Key market players worldwide | Certara Inc Ordinary Shares, Dassault Systemes SE, Avantium NV, Simulations Plus Inc, Schrodinger Inc Ordinary Shares, Chemical Computing Group, Physiomics, Rosa & Co, Genedata AG, Instem, Yokogawa Electric Corp., Immunetrics |
Publish Date: May 29, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Certara Inc Ordinary Shares | View profile | 1,391 | 100 Overlook Center, Suite 101, Princeton, NJ, United States, 08540 | www.certara.com |
| Dassault Systemes SE | View profile | 23,811 | 10, Rue Marcel Dassault, Velizy-Villacoublay, France, 78140 | www.3ds.com |
| Avantium NV | View profile | 249 | Zekeringstraat 29-31, Amsterdam, Netherlands, 1014 BV | www.avantium.com |
| Simulations Plus Inc | View profile | 197 | 42505 Tenth Street West, Lancaster, CA, United States, 93534-7059 | www.simulations-plus.com |
| Schrodinger Inc Ordinary Shares | View profile | 787 | 1540 Broadway, 24th Floor, New York, NY, United States, 10036 | www.schrodinger.com |
| Chemical Computing Group | View profile | 11-50 | Montreal, Quebec, Canada, North America | www.chemcomp.com |
| Physiomics | View profile | 11-50 | Oxford, Oxfordshire, United Kingdom, Europe | www.physiomics-plc.com/ |
| Rosa & Co | View profile | 11-50 | San Carlos, California, United States, North America | www.rosaandco.com |
| Genedata AG | View profile | 51-100 | Basel, Basel-Stadt, Switzerland, Europe | www.genedata.com/ |
| Instem | View profile | 51-100 | Conshohocken, Pennsylvania, United States, North America | www.instem.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biosimulation Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 71.52% in 2025.
Horizon Databook has segmented the Uae biosimulation market based on software, services covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Biosimulation Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE Biosimulation Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
